Authored by NCIA’s Policy Council and member committees, NCIA’s Industry Reports provide accurate, expert insights and research into different issues, trends and challenges impacting our industry.
As cannabis use expands in the U.S., issues that require the guidance of scientists and clinicians are rapidly arising. Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. However, the existing legal environment significantly hinders the ability of clinicians to engage with cannabis research […]
Building New Foundations in the Cannabis Industry: Creating Gender Parity through Ownership, Leadership, Boards, Pay Equality, Branding, and Capital, takes a hard look at gender parity in the U.S. cannabis industry. The research, data, personal stories, and case studies in this series demonstrate why gender parity is crucial to business success. The purpose of this […]
The NCIA environmental committee was formed to write a technical report on “Environmental Impacts, Best Management Practices and Policies for the Cannabis Industry” necessary to position the cannabis industry as a leader in environmental sustainability at the local, state, and national levels and to help inform environmental policy. In this report, we provide a review […]
In October 2020, NCIA submitted comments to the Drug Enforcement Administration (DEA) urging the agency to rescind an interim final rule (IFR) that is in conflict with the hemp provisions of the 2018 Farm Bill and would cause confusion and widespread harm in the burgeoning legal hemp industry in the United States.
In October 2020, NCIA’s Policy Council, Hemp Committee, and Scientific Advisory Committee collaborated to submit comments to the U.S. Department of Agriculture in response to a reopening of the comment period to gather additional information on the establishment of final rules for domestic hemp production.
Law firm of Wilson Elser files Amicus Brief on behalf of NCIA and Arcview in a landmark U.S. Supreme Court case of Washington v. Barr, which challenges the constitutional legality of prohibition.
In September 2020, NCIA’s Policy Council, Hemp Committee, and Scientific Advisory Committee collaborated to submit comments to the Food & Drug Administration in response to a call for guidance on research considerations.
National Cannabis Industry Association Files Amicus Brief in Landmark Cannabis Tax Case National trade organization presents substantive and Constitutional arguments against IRS 280E tax code preventing state-legal cannabis businesses from deducting normal business expenses Harborside Health Center is appealing U.S. Tax Court decision over exorbitant federal tax bill
In May 2020, NCIA submitted comments regarding the DEA’s Request For Information On Controls To Enhance The Cultivation of Marijuana For Research In The U.S.
As reports began to appear of a potential linkage between lung injuries and use of nicotine and/or cannabis vaping products, NCIA’s Policy Council established a Safe Vaping Task Force to provide a consistent response on behalf of the concerned members of the regulated cannabis industry. The Task Force’s mission was to communicate clearly in response […]
In November 2019, NCIA’s Policy Council and Hemp Committee collaborated to submit comments to the U.S. Department of Agriculture on establishing a domestic hemp production program.
In late 2019, the Center for Disease Control (CDC) identified a probable proximate cause of recent vaping injuries and deaths. Shortly after, the United States Senate (HELP Committee) held a hearing on Wednesday, November 13, on the vaping crisis, where CDC officials testified. NCIA Policy Council’s Safe Vaping Task Force also submitted testimony for the […]
With the prohibition era nearing its end, it is imperative to begin discussing how to shape an effective, comprehensive cannabis regulatory framework. The system proposed here would allow all cannabis products to flow to the market through a regulatory scheme designed to best advance the policy goals raised by these products. It builds off the […]
The cannabis industry has evolved into a national commercial enterprise generating significant tax revenue, generating hundreds of thousands of jobs, and providing people access to plant-based medicines that work to alleviate pain and treat symptoms of myriad diseases. State laws that have replaced the criminal markets with systems that provide for tightly regulated production and […]
Deciding what insurance is needed for your cannabis operations can be difficult. This decision is further complicated by the variation in what insurance is mandated by state and local cannabis regulations. This paper attempts to provide some clarity on specific insurance requirements mandated by state and local authorities in several states including California, Colorado, Illinois, […]
On behalf of the National Cannabis Industry Association (NCIA), and in response to the U.S. Food and Drug Administration (FDA) request for comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds, published in the April 3, 2019 edition of the Federal Register, we hereby submit public comments. Given the substantial interest […]
With cannabis now fully legal for adults in ten U.S. states and the District of Columbia – and more elected officials considering legalization in other states every day – it appears as if the complete end of cannabis prohibition is nearly upon us. As we reach this milestone, we must acknowledge that cannabis prohibition was […]